SMAD4 is a potential prognostic marker in human breast carcinomas

Title
SMAD4 is a potential prognostic marker in human breast carcinomas
Authors
Keywords
Ductal breast carcinoma, SMAD4, Immunohistochemistry, Tissue array, Quantitative real-time PCR, Western blot analysis, Prognosis, TGF-β, Non-SMAD signaling
Journal
TUMOR BIOLOGY
Volume 35, Issue 1, Pages 641-650
Publisher
Springer Nature
Online
2013-08-23
DOI
10.1007/s13277-013-1088-1

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started